Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial evaluating the efficacy and safety of Hemay005 Tablets in patients with Behçet's disease. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemay005 Tablets

Snippet

Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: Behçet's Disease | Phase 3 | Status: RECRUITING